IP Verse

Kernebeck patent opposition analysis

The comprehensive analysis of Kernebeck opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Kernebeck

Stay updated with the latest patent oppositions filed by Kernebeck

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4028054
Compositions And Methods Of Treating Lupus NephritisF. HOFFMANN-LA ROCHE AGSep 30, 2026KERNEBECK PATENTANWALTS
EP4438056
Compositions And Methods Of Treating Lupus NephritisF. HOFFMANN-LA ROCHE AGSep 30, 2026KERNEBECK PATENTANWALTS
EP4031110
Dosage Forms For Tyk2 InhibitorsBRISTOL-MYERS SQUIBB COMPANYSep 24, 2026KERNEBECK PATENTANWALTS
EP4000608
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIM INTERNATIONAL GMBHSep 3, 2026STADA ARZNEIMITTEL
EP2396005
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 25, 2026STADA ARZNEIMITTEL
EP3449940
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2026KERNEBECK PATENTANWALTS
EP3500575
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEONE MEDICINES I GMBHAug 5, 2026KERNEBECK PATENTANWALTS
EP3661514
Mavacamten For Use In The Treatment Of Hypertrophic CardiomyopathyMYOKARDIA, INC.Jun 17, 2026KERNEBECK PATENTANWALTS
EP4188389
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECA ABJun 17, 2026STADA ARZNEIMITTEL
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIM INTERNATIONAL GMBHSep 18, 2025STADA ARZNEIMITTEL

Top clients of Kernebeck

Top companies who are the clients of Kernebeck

CompanyTotal
STADA ARZNEIMITTEL49
KERNEBECK PATENTANWALTS9